Home / Learn CBD / CBD or THC for Sleep
CBD vs THC • Insomnia Evidence • REM • Full-Spectrum Context
CBD or THC for Sleep: What Human Research Shows About Insomnia, REM, Next-Day Effects, and Full-Spectrum CBD
CBD and THC are often discussed as if they are interchangeable sleep aids. They are not. Human research shows different effects depending on the cannabinoid, dose, formulation, frequency of use, sleep disorder, and whether investigators measure how someone feels they slept or what objective sleep testing actually shows.
This guide compares the strongest recent evidence, including randomized trials of CBD alone, THC/CBD combinations, systematic reviews of cannabinoid treatment, and sleep-architecture research. It also explains why a lower-dose Full-Spectrum hemp extract is scientifically interesting but cannot be assumed to reproduce the results of purified CBD or higher-THC cannabis studies.
Persistent Sleep Problems Deserve a Real Sleep Evaluation
Difficulty falling asleep can come from chronic insomnia, sleep apnea, restless legs, pain, anxiety or depression, medication effects, alcohol or substance use, circadian disruption, menopause, shift work, or other conditions. Feeling sedated is not the same thing as treating the cause of poor sleep.
Seek urgent medical help for severe trouble breathing, chest pain, overdose concerns, severe confusion, dangerous sedation, suicidal thoughts, or symptoms that feel immediately unsafe.
Medication safety: do not stop, reduce, replace, or combine sleep medications, benzodiazepines, antidepressants, opioids, anxiety medications, or other prescriptions because of CBD or THC information online.
Quick Answer: Is CBD or THC Better for Sleep?
There is no universal winner. Recent research does not support a simple “CBD is better” or “THC is better” answer.
CBD alone has shown mixed results. A 2024 randomized trial of 150 mg nightly CBD in people with moderate-to-severe insomnia found no significant difference from placebo for insomnia severity, sleep onset, sleep efficiency, or wake after sleep onset, although objective sleep efficiency improved after two weeks and wellbeing scores were higher.
THC-containing products can acutely change sleep architecture, but that is not automatically beneficial. A 2025 insomnia study using 10 mg THC + 200 mg CBD reduced total sleep time by about 25 minutes and reduced REM sleep by about 34 minutes compared with placebo.
The most useful conclusion is that cannabinoid sleep effects are formulation-specific and dose-specific, and persistent insomnia should not be managed by choosing a cannabinoid based on a marketing label.
What the Newer Evidence Says at a Glance
CBD 150 mg nightly
In a 2024 pilot insomnia RCT, CBD was similar to placebo for most sleep outcomes. Objective sleep efficiency improved after two weeks, but insomnia severity and self-reported sleep measures did not.
CBD 50 or 300 mg
A 2026 trial in people with high trait worry found that 300 mg performed better than 50 mg on some sleep measures, but not significantly better than placebo.
THC 10 mg + CBD 200 mg
A 2025 pilot insomnia trial found less total sleep, substantially less REM sleep, and slightly more next-day subjective sleepiness after a single dose.
2025 cannabinoid meta-analysis
One meta-analysis of 10 RCTs reported improvements in insomnia severity, sleep quality, total sleep time, efficiency, and sleep onset, but cannabinoid formulations varied.
2026 Cochrane review
A newer Cochrane review concluded medical cannabis may have little to no clinically meaningful effect on sleep quality or total sleep time, with very low certainty and somewhat more adverse events.
Why reviews disagree
They include different products, doses, cannabinoids, populations, durations, and outcome measures. “Cannabinoids” is not one standardized treatment.
How This Page Is Authored and Reviewed
Written by: Bill Polyniak, Founder of Bluegrass Hemp Oil and Kentucky Cannabis Company, for hemp cultivation, Full-Spectrum extraction and formulation, product labels, laboratory testing, and product-quality context.
Clinical review status: this revision is prepared for future pharmacist review of cannabinoid pharmacology, sedation, medication interactions, and clinical-study interpretation. No pharmacist review is claimed on this page until that review is completed.
Last evidence review: November 3, 2026.
Why People Compare CBD and THC for Sleep
CBD and THC can both affect the central nervous system, but they do so differently. THC is intoxicating and can change perception, reaction time, heart rate, mood, and sleep architecture. CBD is non-intoxicating, but it can still cause drowsiness, affect medication metabolism, and produce dose-dependent biological effects.
The comparison becomes confusing because many studies do not test “CBD” or “THC” in the same way. Researchers may study purified CBD, THC alone, CBD/THC combinations, high-THC cannabis, synthetic cannabinoids, or mixed medical-cannabis products.
Before comparing results, ask four questions: Which cannabinoid? What dose? What formulation? What sleep outcome was actually measured?
CBD vs THC: The Sleep-Relevant Differences
| Topic | CBD | THC |
|---|---|---|
| Intoxication | Non-intoxicating. | Intoxicating and can impair judgment or reaction time. |
| Sleep evidence | CBD-only insomnia trials are mixed; several show little difference from placebo on primary sleep outcomes. | THC-containing research is mixed. Some people report easier sleep onset, while objective studies can show altered sleep architecture without better overall sleep. |
| REM | CBD-specific REM effects remain uncertain and dose/formulation dependent. | High-dose or acute THC-containing products can reduce REM in some studies, but the broader evidence is inconsistent. |
| Next-day concerns | Drowsiness is possible. A small 150 mg trial did not impair next-day cognitive performance. | Impairment, sleepiness, altered reaction time, anxiety, and next-day effects can occur depending on dose and timing. |
| Tolerance / withdrawal | Less established as a sleep-specific problem. | Regular cannabis use can lead to tolerance, and withdrawal is consistently associated with sleep disturbance and REM rebound. |
| Full-Spectrum context | Usually the dominant cannabinoid in hemp products. | Present only in trace amounts in legal hemp, but still relevant to drug testing and individual sensitivity. |
Which Cannabinoid Has the Stronger Sleep Case?
CBD has a cleaner impairment profile, but efficacy is uncertain
CBD does not create the intoxication associated with THC. That is attractive for people concerned about next-day function. However, controlled insomnia trials have not consistently shown meaningful improvement over placebo, particularly at 150 mg nightly.
THC may feel sedating, but sedation is not the same as restorative sleep
THC can make some people feel sleepy, but objective studies show that it may also alter REM, total sleep time, and sleep staging. Repeated use introduces tolerance, withdrawal, and dependence considerations that do not appear in a one-night trial.
For chronic insomnia, neither cannabinoid currently has an evidence base that replaces CBT-I. The strongest guideline-backed approach remains cognitive behavioral therapy for insomnia.
Why Recent Reviews Reach Different Conclusions
A 2025 meta-analysis of 10 randomized trials involving 2,134 participants reported statistically significant improvements in insomnia severity, sleep quality, total sleep time, sleep efficiency, and sleep onset with cannabinoid interventions. That sounds encouraging.
But a 2026 Cochrane review reached a more cautious conclusion: medical cannabis may have little to no clinically meaningful effect on sleep quality, total sleep time, or daytime function, and the certainty of the evidence was very low. Adverse events appeared somewhat more common.
| Why results differ | Why it matters |
|---|---|
| Different cannabinoids | CBD, THC, CBN, and mixed formulations should not be treated as one intervention. |
| Different doses | 50 mg CBD and 300 mg CBD are not equivalent exposures, and THC dose changes both effects and risk. |
| Different populations | Healthy adults, people with insomnia, people with pain, and people with anxiety may respond differently. |
| Subjective vs objective sleep | Feeling that sleep improved does not always match actigraphy or polysomnography. |
| Short duration | A few nights or weeks cannot answer long-term tolerance, withdrawal, dependence, or sustained-effect questions. |
REM Sleep, Sleep Architecture, and Next-Day Clarity
REM is one part of normal sleep architecture. Reducing REM is not automatically a benefit. A 2025 pilot trial in 20 people with insomnia found that a single dose of 10 mg THC plus 200 mg CBD reduced REM sleep by about 34 minutes, delayed REM onset by about 66 minutes, and reduced total sleep time by about 25 minutes compared with placebo.
Interestingly, objective next-day alertness, cognition, and simulated driving were not significantly worse at least nine hours later, although participants reported a small increase in subjective sleepiness.
Broader evidence: a 2025 systematic review of cannabis and sleep architecture found that REM suppression is not consistent across studies. Older high-THC experiments were more likely to show REM reduction, while newer studies are mixed. Withdrawal, however, was consistently associated with poorer sleep and REM rebound.
THC: Sedation, Tolerance, Withdrawal, and Sleep Disruption
Intoxication and impairment
THC can impair reaction time, judgment, coordination, and driving ability. Sedation does not guarantee restorative sleep.
Tolerance
With repeated cannabis exposure, some effects can diminish, which may encourage escalating use. Long-term sleep benefits are much less certain than short-term subjective sedation.
Withdrawal sleep problems
Stopping regular cannabis use can produce difficulty falling asleep, shorter total sleep time, vivid dreams, and REM rebound. This can reinforce continued nighttime use.
Observational research also associates regular recreational cannabis use with poorer sleep quality and more insomnia symptoms, although cause and effect are difficult to separate because people with poor sleep may be more likely to use cannabis.
CBD: Dose, Drowsiness, Medication Interactions, and What “Low Dose” Means
CBD is often described as gentle because it is non-intoxicating, but dose matters. A 2026 pharmacology review defined low-dose CBD as up to about 175 mg/day and found that low oral doses produce dramatically lower blood concentrations than prescription-level dosing. It also found little consistent therapeutic effect across many conditions.
Insomnia evidence at 150 mg
The 2024 insomnia RCT found 150 mg nightly CBD similar to placebo for most sleep outcomes, although objective sleep efficiency improved after two weeks.
Next-day cognition at 150 mg
A follow-up analysis found no measurable impairment in attention, executive function, reasoning, information processing, or memory after nightly CBD under trial conditions.
CBD can still interact with medications at consumer-range doses. Low-dose interaction studies have documented changes with some drugs, so “non-intoxicating” should not be confused with “interaction-free.”
For medication-specific evidence, see CBD Interactions.
CBD or THC With Sleep Medications, Alcohol, Sedatives, or Opioids
Do not create a nighttime “stack” of cannabinoids, alcohol, and sedating medication without professional guidance. Drowsiness from multiple substances can add together even when the substances do not have a major pharmacokinetic interaction.
| Combination | Main concern | Better next step |
|---|---|---|
| CBD + prescription sleep medication | Possible additive drowsiness plus medication-specific metabolic interactions. | Have a pharmacist review the exact drug and CBD dose. |
| THC + sedatives or benzodiazepines | Greater impairment, poor coordination, falls, and judgment concerns. | Avoid self-combining; discuss with the prescriber. |
| Cannabinoids + opioids | Sedation and impairment concerns; interaction evidence depends on the exact opioid and cannabinoid exposure. | Use the medication-specific interaction guide and prescriber review. |
| Cannabinoids + alcohol | Potentially greater sedation, impairment, and accident risk. | Avoid assuming a “nightcap” plus cannabinoids is a safe sleep strategy. |
See the CBD Medication Interactions authority guide for the deeper pharmacology.
For Chronic Insomnia, CBT-I Has the Strongest Evidence
The American Academy of Sleep Medicine recommends multicomponent cognitive behavioral therapy for insomnia (CBT-I) for adults with chronic insomnia. CBT-I is more than generic sleep hygiene. It combines behavioral and cognitive techniques such as stimulus control, sleep scheduling, and restructuring unhelpful sleep beliefs.
A 2026 AASM guideline on combination treatment also concluded that CBT-I remains central even when medication is considered. Adding medication may help selected patients early in treatment, but CBT-I alone remains the stronger long-term foundation for many adults.
Ask about sleep apnea
Loud snoring, witnessed breathing pauses, choking, morning headaches, or severe daytime sleepiness deserve evaluation rather than self-treatment with cannabinoids.
Review medications and substances
Stimulants, antidepressants, steroids, alcohol, caffeine, nicotine, THC, and other substances can all affect sleep patterns.
Treat the cause, not only the sensation
Feeling sleepy after a substance is not proof that sleep architecture, insomnia severity, or daytime function improved.
Full-Spectrum context
Where Full-Spectrum CBD Is Scientifically Interesting
A Full-Spectrum hemp extract contains CBD within a broader botanical matrix that may include CBDA, minor cannabinoids, terpenes, flavonoids, and trace THC. That makes it different from the purified CBD used in many insomnia studies and different from high-THC cannabis.
Broader chemistry
Multiple constituents may influence absorption, metabolism, receptor activity, or subjective effects. That possibility is often described as the Entourage Effect.
Much lower THC exposure
Legal Full-Spectrum hemp contains trace THC rather than the THC doses used in many cannabis sleep experiments. That distinction matters for intoxication and REM interpretation.
Direct sleep evidence is limited
Researchers have not established that a lower-dose Full-Spectrum hemp oil improves chronic insomnia or reproduces the effects of purified CBD, THC, or mixed medical-cannabis products.
The opportunity: Full-Spectrum CBD deserves product-specific research because formulation and dose may change exposure and effects. The opportunity is scientifically plausible, but superiority for sleep has not been proven.
If your next question is “what actually makes Full-Spectrum different from purified CBD?”, continue with Full-Spectrum CBD vs. CBD Isolate.
How to Evaluate a Full-Spectrum CBD Product Before Nighttime Use
| Check | Why it matters for sleep-related use |
|---|---|
| CBD per mL | Lets you compare actual CBD exposure with doses used in human trials. |
| THC content | Trace THC matters for sensitivity, impairment, REM questions, and drug testing. |
| Minor cannabinoids | Defines how different the product is from CBD isolate or purified CBD. |
| Carrier oil and ingredients | Formulation and food can affect absorption and tolerability. |
| Batch-specific COA | Verifies the cannabinoid profile and contaminant testing for the exact batch. |
| Medication list | A pharmacist needs the actual CBD/THC exposure and complete medication regimen to evaluate interaction risk. |
Use the Certificates of Analysis and CBD Lab Testing guides to review the product itself.
Where Genesis Blend Fits, and Where It Does Not
Genesis Blend is a retail Full-Spectrum hemp extract, not an FDA-approved insomnia treatment. Its relevance to this discussion is that it represents a very different exposure profile from many clinical cannabinoid sleep studies.
This difference does not prove that Full-Spectrum CBD works at lower doses. It does mean that research on 150–300 mg purified CBD should not be presented as a direct study of Genesis Blend.
Responsible use case: when an adult and their healthcare professional decide to discuss CBD, a clearly labeled, batch-tested Full-Spectrum product gives them a defined formulation to evaluate. It does not replace evaluation of persistent insomnia or another sleep disorder.
If you want to understand why equal milligrams can still produce different exposure, the next useful read is CBD Absorption & Bioavailability.
Choose your next question
What Do You Want to Understand Next?
Frequently Asked Questions About CBD or THC for Sleep
Is CBD or THC better for sleep?
Current evidence does not support one universal answer. CBD-only trials are mixed, while THC-containing products may cause sedation but can also alter REM, impair alertness, and create tolerance or withdrawal concerns.
Does CBD help insomnia?
A 2024 randomized trial of 150 mg nightly CBD found no significant improvement over placebo for insomnia severity or most self-reported sleep outcomes, although objective sleep efficiency improved after two weeks. More research is needed.
Does THC help you fall asleep?
THC can feel sedating to some people, but sedation is not the same as proven treatment of insomnia. Objective studies and reviews show mixed sleep effects, and regular use introduces tolerance, impairment, and withdrawal concerns.
Does THC reduce REM sleep?
Some acute high-THC or THC-containing studies show REM suppression, but a 2025 systematic review found the overall REM evidence inconsistent. Cannabis withdrawal is more consistently associated with REM rebound and disturbed sleep.
Can CBD cause next-day impairment?
CBD can cause drowsiness, but a small randomized study using 150 mg nightly for two weeks did not find measurable impairment in attention, executive function, reasoning, processing speed, or memory the following day.
Can CBD interact with sleep medications?
Yes. CBD can affect some drug-metabolizing pathways, and drowsiness can add to the effects of sleep medications or other sedating substances. A pharmacist should review the exact medication and CBD exposure.
Can I mix CBD or THC with alcohol?
Combining cannabinoids with alcohol may increase sedation, impairment, poor coordination, and accident risk. Do not assume a cannabinoid plus alcohol is a safe sleep strategy.
Is Full-Spectrum CBD the same as CBD used in insomnia trials?
No. Many insomnia studies use purified CBD at defined doses. Full-Spectrum hemp extracts contain CBD plus other plant constituents and trace THC, so the results cannot be assumed to transfer directly.
Could the Entourage Effect make Full-Spectrum CBD work differently?
It is scientifically plausible that broader plant chemistry can alter pharmacology or exposure, but controlled insomnia trials have not established that the Entourage Effect makes Full-Spectrum CBD superior for sleep.
Is Genesis Blend a sleep treatment?
No. Genesis Blend is a retail Full-Spectrum CBD product and is not an FDA-approved insomnia or sleep-disorder treatment.
What is the best-established treatment for chronic insomnia?
Guidelines from the American Academy of Sleep Medicine recommend multicomponent cognitive behavioral therapy for insomnia, or CBT-I, as a first-line treatment for chronic insomnia in adults.
What This Means if You Are Considering Full-Spectrum CBD at Night
There is a reasonable scientific basis for studying cannabinoids and sleep, but the strongest newer evidence does not support a simplistic claim that CBD or THC is “best for sleep.”
- CBD has a lower intoxication burden than THC, but CBD-only insomnia efficacy remains uncertain.
- THC can change sleep architecture and may feel sedating, but acute sedation can coexist with reduced REM, shorter total sleep, impairment, tolerance, or withdrawal-related sleep problems.
- Full-Spectrum hemp sits between those research categories because it is CBD-dominant but contains broader plant chemistry and trace THC.
- That makes product-specific Full-Spectrum research worthwhile, but it does not establish Full-Spectrum CBD as a treatment for insomnia.
Medical and Safety Notice
This page is educational and does not diagnose insomnia, sleep apnea, anxiety, pain, PTSD, or another condition. It does not recommend starting, stopping, reducing, replacing, or combining prescription medication with CBD or THC.
Retail CBD and THC products are not FDA-approved treatments for chronic insomnia. If sleep problems are persistent, severe, worsening, or disrupting daytime function, seek evaluation from a qualified healthcare professional.
Primary Research and Clinical Guidance
- Narayan et al. (2024): 150 mg nightly CBD for moderate-to-severe insomnia
- Narayan et al. (2025): next-day cognitive performance after nightly 150 mg CBD
- 2026 randomized CBD trial in adults with high trait worry
- 2025 pilot RCT: 10 mg THC + 200 mg CBD and objective sleep architecture
- 2025 systematic review and meta-analysis of cannabis and sleep architecture
- 2026 meta-analysis of randomized cannabinoid trials for insomnia and sleep disturbance
- 2026 Cochrane review: medical cannabis for insomnia
- 2026 review of low-dose CBD pharmacology, efficacy, and drug interactions
- American Academy of Sleep Medicine: CBT-I clinical practice guideline
- 2026 AASM guideline on CBT-I and combination treatment